GR8 was founded in 2008 by Jayne Mackta, a vocal and visionary advocate for biomedical research for over 20 years. As founding President of the New Jersey Association for Biomedical Research, she led a proactive coalition of stakeholders from industry, academia, healthcare organizations and patient groups that campaigned vigorously to foster public understanding of the vital role of animals in research. Leveraging the expertise, commitment and compassion of colleagues engaged in every aspect of laboratory animal care and use, she has developed a strategic consortium dedicated to promoting world-class education & training wherever animal research is performed. One of the fundamental drivers of GR8 is the belief that public trust in the process and products of biomedical research can be restored through collaborative initiatives that promote “training people can trust.”
A Three-Part GR8 Webinar Series
GLOBALIZING ANIMAL RESEARCH: WHAT’S AT STAKE?
Part One: Balancing Risks & Opportunities - Now available on demand
Part Two: What Global Pharmas Want & Why - Now available on demand
Part Three: Why China? Why Now? - 7/21 - 10 – 11 AM (EST)
Presenters: Dr. Christer Safholm, Vice President Safety Assessment, AstraZeneca
Dr. Steve Yang, VP, Head of Pfizer Asia R&D
Moderator: Dr. Kathryn Bayne, Global Director, AAALAC International
Global Sponsors
AstraZeneca * Bristol-Myers Squibb * Lilly
GlaxoSmithKline * Pfizer * Roche * sanofi-aventis
Registration
Individual Sessions: Part One/ $125; Part Two/ $200; Part Three/ $125
Important Notes: All sessions will be recorded and will be available on-demand. If you are unable to participate in the live sessions, be sure to register for the series on-demand so that you can access these timely and informative programs at your convenience.
You will listen to the audio portion of this event via streaming audio through your computer speakers. You must have computer speakers to participate in this program.